JAMA+ AI

JAMA+ AI is a window into the scientific content, educational reviews, and commentary on AI & medicine published across the @JAMANetwork family of journals.

[JAMA+ AI @JAMAplusAI]

Announcing the launch of JAMA+ AI, an engaging, interactive channel that amplifies the best of the JAMA Network’s content exploring the science of artificial intelligence and digital medicine and its application in health and health care. https://t.co/VleLWv23se

[JAMA+ AI @JAMAplusAI]

Yulin Hswen, ScD, MPH, Associate Editor of @JAMA_current and @JAMAplusAI, recently moderated “Can AI Help Health Policy?” at the #AI for Health: Power, Promise, and Public Good Symposium at @WashU.

🔗 Read the latest research and commentary from JAMA+ AI: https://t.co/l3xcC2s1VI

[JAMA+ AI @JAMAplusAI]

From @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.

https://t.co/rYZP1GGACj

#ScientificSessions26

[JAMA+ AI @JAMAplusAI]

A recent JAMA Dermatology study that incorporated this design found that AI tools may help consumers better understand skin conditions. Accuracy was higher in the AI-based groups, with the Wizard of Oz group performing best.

📌 Listen to more: https://t.co/v4uWJWM4hd

[JAMA @JAMA_current]

#AI is rapidly entering health care, but adding more technology does not necessarily improve care and may add to alarm fatigue in already crowded clinical environments.

🎙️ In this episode of JAMA+ AI Conversations, @JAMA_current and @JAMAplusAI Associate Editor Yulin Hswen, ScD, MPH, spoke with Bon Ku, MD, MPP, program manager at @ARPA_H about how simulation-based testing may help assess artificial intelligence systems before they are used in real-world care.

https://t.co/e7ARpUBleM

[JAMA @JAMA_current]

As #AI enters clinical care, women #physicians may face greater risk of adverse effects if these tools amplify inequities already present in #medicine.

🎙️ In the latest episode of JAMA+ AI Conversations, @JAMAplusAI Editor in Chief Roy Perlis, MD, MSc, spoke with Rochelle P. Walensky, MD, MPH, about how differences in administrative burden, electronic health record use, and patient messaging could shape who benefits from artificial intelligence in practice.

https://t.co/hSM73DOTaG

[Rohit Vashisht @Vashishtrv]

Congratulations Dr. Perlis, and welcome to @UCSF

[UCSF Bakar Computational Health Sciences Institute @UCSF_BCHSI]

Big news! We welcome @JAMAplusAI Editor in Chief Dr. Roy Perlis as our new director. https://t.co/DozAjPcNZH @UCSFMedicine @UCSFHospitals @UCSF

[Bob Wachter @Bob_Wachter]

Thrilled that Roy Perlis @royperlis, Professor @Harvard & Mass General, head of MGH Center for Quantitative Health, & editor of @JAMAplusAI will be the new director of @UCSF Baker Computational Health Sci Institute. I chaired the search and Roy is superb.
https://t.co/VfOlEbyvYE

[JAMA @JAMA_current]

🎙️ In this episode of JAMA+ AI Conversations, @JAMAplusAI Editor in Chief Roy Perlis, MD, MSc, and @EricTopol, MD, discuss what it may take for artificial intelligence to help move medicine from reactive care to prediction and prevention.

https://t.co/SRv3skWnyv

[JAMA+ AI @JAMAplusAI]

Congratulations to @JAMAplusAI Editor in Chief Roy Perlis, MD, MSc, on his appointment as Director of @UCSF_BCHSI and Priscilla Chan and Mark Zuckerberg Distinguished Professor at @UCSF.

https://t.co/Z7O3bEtEup

[UCSF School of Medicine @UCSFMedicine]

We are pleased to announce the appointment of Roy H. Perlis, MD, MSc, as director of @UCSF_BCHSI effective February 1, 2027. Read more about Dr. Perlis: https://t.co/PmKB45oPKY

[JAMA+ AI @JAMAplusAI]

🎙️ In the latest episode of JAMA+ AI Conversations, Roy Perlis, MD, MSc, spoke with Rochelle Walensky, MD, MPH, about how differences in administrative burden, electronic health record use, and patient messaging could shape who benefits from #AI.

https://t.co/ic2Ix7o3qe

[JAMA+ AI @JAMAplusAI]

🎙️ In this episode of JAMA+ AI Conversations, Yulin Hswen, ScD, MPH, spoke with Bon Ku, MD, MPP, program manager at @ARPA_H about how simulation-based testing may help assess artificial intelligence systems before they are used in real-world care.

https://t.co/kBohsNKfs2

[JAMA+ AI @JAMAplusAI]

📊 Research Summary: Among adults with established #atherosclerotic #cardiovascular disease or high cardiovascular risk and recent #Statin nonadherence, digital outreach improved 14-day statin refill vs usual communication.

https://t.co/yqmIlZX571

[JAMA+ AI @JAMAplusAI]

💬 Editorial: Digital outreach by nonsecure email, short message service, or secure portal messaging improved #Statin refill rates among patients with established atherosclerotic cardiovascular disease or high #cardiovascular risk and recent nonadherence.

https://t.co/vNFXim4URM

[JAMA+ AI @JAMAplusAI]

Among adults with established #AtheroscleroticCardiovascularDisease or high cardiovascular risk and recent #Statin nonadherence, digital outreach improved 14-day statin refill vs usual communication.

🔗 https://t.co/PE1UC5O0Rk

[JAMA+ AI @JAMAplusAI]

@washingtonpost @JAMANetworkOpen ➡️ Interested in learning more about the role of artificial intelligence and digital #medicine in #health care?

Follow @JAMAplusAI and subscribe to the newsletter for accessible, timely #AI content: https://t.co/LziDfcLnEH

[JAMA+ AI @JAMAplusAI]

Featured in @washingtonpost: JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, discussed her recent @JAMANetworkOpen study examining the gap between women's reported #menopause experiences and what is documented in #clinicalcare.

https://t.co/5loi3mmQvm

[JAMA+ AI @JAMAplusAI]

@washingtonpost @JAMANetworkOpen Read the @JAMANetworkOpen article, “Divergence in Menopause Symptom Narratives Between Online and Clinical Settings”:

🔗 https://t.co/si8RW3FUXT